
The Chemours Company
NYSE•CC
CEO: Ms. Denise M. Dignam
Sector: Basic Materials
Industry: Chemicals - Specialty
Listing Date: 2015-06-19
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for electronics, communications, transportation, wire and cable, energy, oil and gas, and medical, and other applications under the eflon, Viton, Krytox, and Nafion brands. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.
Contact Information
Market Cap
$1.94B
P/E (TTM)
-5.8
19.1
Dividend Yield
4.0%
52W High
$20.12
52W Low
$9.13
52W Range
Rank51Top 58.4%
3.4
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Weak • 3.4 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2015-2024
Financial Dashboard
Q3 2025 Data
Revenue
$1.50B-0.40%
4-Quarter Trend
EPS
$0.00+0.00%
4-Quarter Trend
FCF
$105.00M+66.67%
4-Quarter Trend
2025 Q3 Earnings Highlights
Key Highlights
Strong Quarterly Profitability Turnaround Net income attributable to Chemours $60M versus prior year loss of ($32)M for the three months ended September 30, 2025.
9M Operating Cash Flow Reversal OCF $127M provided versus ($771)M used, driven by $592M restricted cash release from settlement fund.
Net Sales Show Modest Growth Nine months Net Sales grew 1% to $4.478B, volume up 2% offsetting 1% price decrease across segments.
Gross Profit Under Pressure Nine months Gross Profit fell 15% to $746M due to $186M higher Cost of Goods Sold from raw materials.
Risk Factors
Major Litigation Expense Surge Nine months litigation charges totaled $301M, primarily due to $263M recorded for the New Jersey settlement agreement.
Substantial Environmental Liabilities Total environmental remediation reserves stand at $609M; Fayetteville site accounts for $327M of this accrued liability.
Regulatory Uncertainty Impacts Evolving PFAS regulations, especially EPA MCLs, could materially increase future environmental remediation costs and obligations.
Significant Equity Reduction Total Equity decreased to $300M from $588M, reflecting the $325M net loss recorded for the nine months period.
Outlook
Credit Facility Maturity Extended Amended credit agreement extends Term Loan maturity to October 2032 and increases aggregate revolving capacity to $1.0B.
Supply Chain Strategic Agreement Strategic agreement signed with SRF Limited in August 2025 to bolster fluoropolymer supply chain flexibility and capacity.
Focus on Climate Goals Commitment to 60% reduction in Scope 1 and 2 absolute GHG emissions by 2030 remains a key strategic focus.
Debt Repayment Schedule Quarterly principal payments required on Dollar Term Loan through June 2028, with leverage impacting future payments.
Peer Comparison
Revenue (TTM)
LIN$33.50B
LYB$32.56B
PPG$14.13B
Gross Margin (Latest Quarter)
58.3%
ESI42.2%
PPG40.6%
Key Metrics
Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets |
|---|---|---|---|---|
| LIN | $194.42B | 27.5 | 18.5% | 27.4% |
| APD | $54.09B | -137.2 | -2.5% | 44.6% |
| PPG | $23.23B | 23.4 | 13.7% | 35.7% |
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
2.4%
Moderate Growth
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
75%
Volatile Cash Flow
Research & Insights
Next earnings:Feb 17, 2026
EPS:$0.06
|Revenue:-
Reports
All Years
Form 10-Q - Q3 2025
Period End: Sep 30, 2025|Filed: Nov 6, 2025|Revenue: $1.50B-0.4%|EPS: $0.00+0.0%N/AForm 10-Q - Q2 2025
Period End: Jun 30, 2025|Filed: Aug 5, 2025|Revenue: $1.62B+5.0%|EPS: $-2.54-640.4%MissForm 10-Q - Q1 2025
Period End: Mar 31, 2025|Filed: May 6, 2025|Revenue: $1.37B+1.3%|EPS: $-0.03-107.6%MissForm 10-K - FY 2024
Period End: Dec 31, 2024|Filed: Feb 18, 2025|Revenue: $5.78B-4.1%|EPS: $0.58+136.3%BeatForm 10-Q - Q3 2024
Period End: Sep 30, 2024|Filed: Nov 4, 2024|Revenue: $1.50B+0.9%|EPS: $-0.18-238.5%MissForm 10-Q - Q2 2024
Period End: Jun 30, 2024|Filed: Aug 1, 2024|Revenue: $1.54B-6.4%|EPS: $0.47-118.7%MissForm 10-Q - Q1 2024
Period End: Mar 31, 2024|Filed: Apr 30, 2024|Revenue: $1.35B-12.1%|EPS: $0.35-63.9%BeatForm 10-K - FY 2023
Period End: Dec 31, 2023|Filed: Mar 27, 2024|Revenue: $6.03B-11.3%|EPS: $-1.60-143.0%Miss